Plus Therapeutics, Inc. (PSTV)

NASDAQ: PSTV · IEX Real-Time Price · USD
1.72
+0.09 (5.52%)
At close: Nov 27, 2023, 4:00 PM
1.65
-0.07 (-4.07%)
Pre-market: Nov 28, 2023, 4:00 AM EST

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 1998
Revenue
0.2200.372.986.4111.3811.667.612.2
Upgrade
Revenue Growth (YoY)
---95.67%134.60%-53.47%-43.66%-2.39%53.45%-37.70%-15.90%
Upgrade
Cost of Revenue
000001.322.173.192.943.42
Upgrade
Gross Profit
0.2200.372.985.099.218.474.668.78
Upgrade
Selling, General & Admin
10.246.856.415.296.2211.1912.1712.4322.3625.06
Upgrade
Research & Development
9.75.322.75.375.5211.6816.21915.1117.07
Upgrade
Other Operating Expenses
00.320.78001.690000
Upgrade
Operating Expenses
19.9412.499.8910.6611.7524.5528.3731.4337.4642.12
Upgrade
Operating Income
-19.71-12.49-9.58-3.66-8.76-19.46-19.16-22.95-32.81-33.35
Upgrade
Interest Expense / Income
0.710.931.111.861.922.052.593.384.373.4
Upgrade
Other Expense / Income
-0.15-0.03-2.455.381.951.180.29-7.590.19-10.57
Upgrade
Pretax Income
-20.28-13.4-8.24-10.89-12.63-22.69-22.05-18.74-37.37-26.18
Upgrade
Net Income
-20.28-13.4-8.24-10.89-12.63-22.69-22.05-18.74-37.37-26.18
Upgrade
Preferred Dividends
0000.552.493.9800.661.170
Upgrade
Net Income Common
-20.28-13.4-8.24-11.44-15.12-26.66-22.05-19.41-38.54-26.18
Upgrade
Shares Outstanding (Basic)
2100000000
Upgrade
Shares Outstanding (Diluted)
2100000000
Upgrade
Shares Change
117.18%173.03%219.93%696.08%168.36%87.30%84.27%74.13%19.24%15.52%
Upgrade
EPS (Basic)
-11.54-16.64-27.89-123.99-1304.05-6169.41-9595.20-15517.24-53946.04-43831.16
Upgrade
EPS (Diluted)
-11.54-16.64-27.89-123.99-1304.05-6169.41-9595.20-15517.24-53946.04-43831.16
Upgrade
Free Cash Flow
-13.48-10.36-8.53-5.97-12.11-18.31-19.47-21.07-31.02-30.08
Upgrade
Free Cash Flow Per Share
-7.70-12.85-28.87-64.70-1044.17-4237.64-8440.52-16825.37-43127.64-49878.63
Upgrade
Gross Margin
100.00%-100.00%100.00%100.00%79.44%80.93%72.67%61.31%71.95%
Upgrade
Operating Margin
-8800.00%--3163.04%-52.26%-293.73%-303.51%-168.37%-196.88%-431.77%-273.43%
Upgrade
Profit Margin
-9051.34%--2719.80%-163.49%-506.91%-415.89%-193.73%-166.44%-507.20%-214.64%
Upgrade
Free Cash Flow Margin
-6018.30%--2814.19%-85.35%-405.90%-285.60%-171.08%-180.70%-408.24%-246.65%
Upgrade
EBITDA
-18.85-12.05-6.77-8.12-8.71-18.49-18.27-14.27-32.22-21.15
Upgrade
EBITDA Margin
-8416.07%--2232.67%-116.09%-291.92%-288.35%-160.56%-122.41%-424.03%-173.43%
Upgrade
Depreciation & Amortization
0.710.420.370.9122.151.181.090.781.63
Upgrade
EBIT
-19.56-12.47-7.13-9.03-10.71-20.64-19.45-15.37-33-22.78
Upgrade
EBIT Margin
-8733.93%--2354.46%-129.07%-359.10%-321.90%-170.95%-131.79%-434.29%-186.79%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).